



    




Objective: The purpose is to examine how robotic assisted mitral valve repair affects surgical 
outcomes for patients with degenerative mitral valve disease. Methods: A comprehensive 
literature review was conducted by examining literature from the MEDLINE database. Research 
articles, literature reviews, and statistical reports were accessed using PubMed through the 
UMD Database Finder. Literature which examined the surgical outcomes of RMVR and its 
comparison with conventional mitral valve repair (CMVR) were analyzed. Results: The literature 
shows consistent surgical outcomes for mortality, morbidity, and mitral valve durability for 
patients who underwent RMVR. However, cardiopulmonary bypass (CB) and cross clamp (XC) 
times are significantly longer, hospital stay times are significantly shorter, and the quality of life 
for patients is significantly higher. Conclusions: RMVR is a safe and effective operation which 
provides consistent and even superior surgical outcomes for patients with degenerative mitral 
valve disease. Further research into long term mitral valve durability (>5 years) for patients who 
underwent RMVR is recommended.  
Introduction 
 The heart is an essential organ which powers the cardiovascular system of the human 
body. Cardiac function is responsible for adequately pumping blood throughout the body, which 
is essential for nutrient transport, oxygen delivery, and carbon dioxide expulsion. Unfortunately, 
cardiovascular disease is the leading cause of death in the United States, with cardiovascular 
issues being responsible for 1 in 4 deaths (Benjamin et al., 2017). Therefore, the clinical 
advancement of cardiovascular medicine is crucial for mitigating deaths due to cardiovascular 
pathologies.  
 The primary aim of cardiovascular medicine, including cardiothoracic surgery and 
cardiology, is to correct, reduce, or prevent cardiac pathology. The heart acts as a double pump, 
pumping oxygen deficient blood to the lungs for oxygenation, and then pumping the returning 
oxygenated blood to the rest of the body. To ensure proper blood flow, the heart contains four 
valves which prevent blood from regurgitating backwards. The valves continuously open and 
close, making the valves prone to degenerative disease over the course of a lifetime. The mitral 
valve, which regulates blood flow between the left atrium and the left ventricle, is most 
susceptible to degenerative damage. Since the left ventricle pumps blood throughout the entire 
body, the mitral valve is under higher pressure when regulating blood flow.  
 Mitral valve disease is typically a degenerative process which results in mitral valve 
prolapse, or an improper movement of the leaflet. Mitral valve degenerative disease may result 
in stenosis or regurgitation of the valve, interfering with blood flow and causing the heart to work 
harder. Impaired cardiac function leads to poor cardiovascular function, making it more difficult 
for patients to perform day to day activities. As the mitral valve degenerates more and more, its 
impaired function can lead to heart failure, which can eventually lead to death. To prevent 
further mitral valve degeneration and to prevent regurgitation, cardiothoracic surgeons can 
perform mitral valve repair, a commonly practiced open heart surgery (Cohn et al., 2015).  
 Mitral valve repair is a surgical procedure aimed at repairing mitral valve leaflet prolapse, 
so that proper function of the mitral valve is restored as much as possible. The practice of mitral 
valve repair has drastically changed clinical outcomes for patients with mitral valve disease, 
making is possible for patients to achieve full function of the mitral valve post-surgery. This 
procedure can be performed through three main approaches: conventional, mini, and robotic. In 
the conventional approach, a full sternotomy is performed and the surgeon uses his/her hands 
to repair the mitral valve. The mini approach utilizes a smaller incision for the sternotomy, 
reducing the trauma done to the sternum. The third approach, and more recently developed, is 
the robotic approach which utilizes robotic machinery (Da Vinci System) to repair the mitral 
valve. 
 RMVR is currently the least invasive option for anatomically repairing the mitral valve, 
utilizing a right thoracotomy rather than a conventional sternotomy. The implementation of 
RMVR into surgical practice poses huge questions on how it is affecting patient outcomes. 
Currently, it is still being debated within literature about which surgical approach provides the 
most optimal surgical outcomes for patients (Gillinov et al., 2016). This literature review looks at 
the implications of robotic assisted mitral valve repair on the surgical outcomes of patients with 
degenerative mitral valve disease. The work starts by discussing the development of mitral 
valve surgeries into present day. Then, the paper discusses the surgical outcomes of robotic 
mitral valve repair, including mitral valve durability, hospital stay time, cardiopulmonary bypass 
and cross clamp time, stroke risk, mortality risk, and quality of life. Lastly, the paper discusses 
the efficacy and safety of practicing robotic repair by assessing the quality of surgical outcomes.  
History 
 Although cardiac procedures are routinely performed today, the world of medicine was 
resistant to cardiac procedures in the 19th and 20th centuries. The inability to operate on a 
beating heart made cardiac surgery a notion outside the capabilities of medicine. There were, 
however, few innovative surgeons who attempted novel cardiac procedures, leading the way to 
the development of open-heart surgery. In the late 19th century, Dr. Henry Dalton become the 
first surgeon to successfully repair a pericardial wound, and thus cardiac surgery was born 
(Weisse, 2011).  
 As extracardiac surgeries became more prominent, surgeons were faced with the 
ultimate challenge: performing open heart surgery. To be able to perform open heart surgery, 
the circulatory system must be redirected so that the heart stops beating. In the late 20th 
century, the cardiopulmonary bypass machine was developed, allowing surgeons to medically 
induce cardiac arrest without the presence of blood flow, thus granting access to the heart 
(Weisse, 2011). The cardiopulmonary bypass machine acts as an outside heart by oxygenating 
the blood outside of the body and redirecting blood flow so that the heart can be bypassed. 
Since surgeons now had direct vision into the heart, a variety of cardiac pathologies were now 
capable of surgical correction.  
 With the development of the cardiopulmonary bypass machine, many surgeons looked 
to repair valvular pathologies. In 1983, Dr. Alain Carpentier published a paper called “The 
French Correction”, which outlined the “pathophysiological complications of mitral valve lesions” 
and provided a process for performing consistent and effective mitral valve repair (Cohn et al., 
2015). The paper inspired surgeons to perform more mitral valve repairs, and subsequently the 
rate of mitral valve repairs increased dramatically.  
 Early mitral valve repairs were performed by doing a complete sternotomy. To avoid 
complications with sternal trauma, many surgeons began practicing minimally invasive mitral 
valve repair which utilizes a smaller incision in the sternum. Minimally invasive mitral valve 
repair has been found to “decrease trauma, blood transfusion requirements, and costs” (Cohn et 
al., 2015). However, the success of this procedure relative to the conventional approach is 
dependent on the quality of mitral repair performed.  
 In the early 21st century, many tertiary hospitals began to use robotic assisted mitral 
valve repair (RMVR) for treating mitral valve regurgitation. Currently, the adoption of RMVR 
remains questioned by many surgeons due to concerns over “patient safety, mitral valve repair 
rates, and procedural complexity” (Gillinov et al., 2016). Although RMVR has become a 
standard at many hospital centers, the quality of its surgical outcomes and its relation to a 
traditional sternotomy still needs to be assessed. To address the efficacy and safety for RMVR, 
the surgical outcomes for patients with degenerative mitral valve disease will be assessed for 
quality and compared with the conventional approach. 
Current Research 
 To understand the implications RMVR has on patients with degenerative mitral valve 
disease, the surgical outcomes of patients will be assessed by discussing primary literature of 
RMVR. The primary literature focuses on echocardiographic data (mitral valve durability), 
hospital stay time, cardiopulmonary bypass (CB), cross-clamp times (XC), morbidity risk, 
mortality risk, and the quality of life.  
Mitral Valve Durability 
 The primary purpose of mitral valve repair is to anatomically repair the prolapsed mitral 
leaflet to reduce mitral regurgitation (MR). Consequently, the overall success of this procedure 
is determined by how durable the mitral valve is post-operation. A durable mitral valve post-
surgery ensures minimal regurgitation of blood, and thus a reduction of symptoms for the 
patient. If the mitral valve continues to prolapse significantly post repair, then the operation has 
failed to correct the valvular pathology. The durability of the mitral valve is a crucial surgical 
outcome which must be considered when assessing the efficacy of a mitral valve repair.  
 In a study at a Korean Institution, the long-term mitral valve durability of patients whom 
underwent RMVR was assessed by analyzing echocardiographic reports for 310 patients. The 
pre-discharge echocardiogram displayed minimal mitral valve regurgitation (MR), indicating that 
RMVR is successful in the short term. To assess the long-term mitral valve durability, late 
echocardiographic reports (> 6 months) showed that 86.5% of patients were free from 
significant mitral valve regurgitation. Although 10.8 % of patients developed significant mitral 
valve regurgitation, the long-term success in the majority of patients showed that RMVR is a 
safe procedure with acceptable long-term mitral valve durability (Kim et al., 2017).  
 Another study at a European Center examined echocardiographic data for mitral valve 
durability in the short term and long term for patients who underwent RMVR (Navarra et al., 
2017). The study found that all patients had none to minimal MR when assessing the pre-
discharge echocardiograms. In the long term, 92.5 % of patients were found to have freedom 
from MR at 12 months and 80.6 % of patients had freedom from MR at 36 months (Navarra et 
al., 2017). This study also indicated that the use of RMVR yields excellent short term and long-
term mitral valve durability for patients.  
 To better understand the long-term durability of the mitral valve post robotic repair, a 
third study examines echocardiographic follow ups with 81 patients who underwent RMVR. The 
analysis found that only 4.9% of patients experienced significant mitral valve regurgitation post-
operation, with an average echocardiographic follow up of 36 months post-surgery (Wang et al., 
2016). These results support previous studies indicating that RMVR has excellent outcomes for 
mitral valve durability. 
 The literature suggests that the use of RMVR has excellent outcomes for mitral valve 
durability in the short term and long term for patients. This indicates that the repair done through 
the Da Vinci system is a viable alternative to a repair done through the conventional approach. 
Hospital Stay Time 
 The amount of time a patient must spend recovering in the hospital after surgery is 
important when considering how effective the surgery is. Surgeries which allow for fewer 
incisions and less trauma are typically preferred over more invasive surgeries to allow for 
quicker recovery times for patients. In this section, the hospital stay length will be assessed for 
patients whom underwent RMVR and compared with patients whom underwent CMVR.  
 In a study by Dr. Hawkins, data of 2300 patients from the Society of Thoracic Surgeons 
were extracted and stratified by approach, including the robotic, mini, and conventional 
approach (Hawkins et al., 2018). The study found that patients who underwent RMVR had lower 
lengths of stay in the hospital when compared with patients who underwent the conventional 
approach. The results of this study show that perhaps the less invasive thoracotomy performed 
in the robotic approach yields faster recovery times than a sternotomy. Other literature also 
supports RMVR yielding shorter hospital times for patients. In another study aimed at assessing 
perioperative outcomes of RMVR and non-robotic approaches, it was found that there was a 
significant decrease in hospital stay times for patients who underwent RMVR (Paul et al., 2015). 
In a third study examining success of RMVR vs nonrobotic surgery in older patients, patients 
who underwent robotic surgery had faster recovery times (Wang et al., 2018).  
 However, some literature reports finding no difference in post-operative stay between 
the robotic and conventional approach. In a metanalysis aimed at assessing the surgical 
outcomes of RMVR, data analysis found no significant difference in hospital stay between both 
approaches (Cao et al., 2015).  However, the authors emphasize interpreting the results with 
caution, as the patients used for the metanalysis have differing characteristics. 
 Most literature on clinical outcomes of RMVR indicate that the procedure yields shorter 
recovery time in the hospital; however, a single metanalysis provides evidence to the contrary. 
The difference in hospital stay time is most likely caused by the respective incisions made in 
each approach, with the robotic approach on the more minimally invasive end. The shorter 
hospital stay times indicate that RMVR may provide superior recovery times when compared 
with CMVR. 
Cardiopulmonary Bypass and Cross-Clamp Time; Morbidity (stroke risk)  
 The cardiopulmonary bypass machine redirects blood from the heart and allows 
surgeons to operate on the heart during cardiac arrest. To use bypass, the aorta must be 
clamped to prevent blood flow into the heart while surgery is being performed (cross clamp 
time). Unfortunately, cardiopulmonary bypass comes with its own complications, including 
inflammation of the blood and an increased risk of embolisms. The rotor machinery used to 
pump blood can damage red blood cells and facilitate the formation of embolisms, which can 
lead to stroke and renal failure. To assess the efficacy of an open-heart surgery, the length of 
cardiopulmonary bypass (CB), length of cross-clamp (XC) time, and risk for stroke must be 
examined.  
 In a systematic review examining the clinical outcomes and cost effectiveness of RMVR, 
data from 27 papers were extrapolated, with 16 of the papers having data from greater than 50 
patients. From the metanalysis, the CB and XC times were found to be longer in the robotic 
approach when compared to times in the conventional approach (Seco et al., 2013). Other 
individual studies also yielded similar results regarding CB and XC times. In the beginning 
stages of RMVR, the FDA approved a phase II trial of several patients undergoing RMVR. For 
this clinical study, researchers examine the safety of using RMVR by examining clinical 
outcomes for 112 patients with mitral valve disease. The results provide especially long CB and 
XC times, and researchers recommended advances in robotic technology to help decrease the 
procedural time for RMVR (Nifong et al., 2005).  
  Although literature shows that CB and XC are longer in the robotic approach, the risk for 
stroke is found to be at an acceptable level, and even similar to stroke risk from the 
conventional approach. In a study examining the first 1000 cases of RMVR at a tertiary center, 
the stroke risk was found to be 1.4%, a relatively low risk for patients (Gillinov et al., 2018). In 
another study examining surgical complications between the two approaches, the risk for stroke 
was found to be similar for both approaches (Paul et al., 2015). 
 The literature shows that although CB and XC times are longer for the robotic approach, 
the risk for stoke is acceptable and corresponds with stroke risk from the conventional 
approach.  
Mortality  
The mortality risk represents how many patients survive an operation, providing insight 
into how risky or effective a given surgery is. The mortality rate is indicative of how successful a 
given operation is, therefore the mortality rate for RMVR will be assessed in terms of risk and 
comparison to the conventional approach. 
Two studies show that the mortality risk for RMVR is acceptable and low. In the first 
study, the first 1000 cases of RMVR at a tertiary center are examined for the safety and efficacy 
of the procedure. The mortality risk was found to be 0.1% for patients, an acceptable and “low 
operative mortality” (Gillinov et al. 2018). In another study examining perioperative outcomes 
between the robotic and non- robotic approach, 3147 cases of RMVR were examined for rates 
of mortality and morbidity. The rates of mortality are found to be acceptable and similar between 
both approaches (Paul et al., 2015). 
The literature primarily shows that mortality risk is acceptable and relatively low for 
RMVR, and similar to mortality rates found through the conventional approach. The rates of 
mortality indicate that RMVR is a safe procedure for patients with degenerative mitral valve 
disease.  
Quality of Life 
 The quality of life indicates how satisfied the patient is with their lives post-surgery. Most 
literature does not address this clinical outcome, as it is difficult to operationalize. Nonetheless, 
it is an important surgical outcome to examine when assessing the implications of a certain 
operation. From all the literature examined, one study uses a quality of life (QOL) survey to 
assess the quality of life for patients who underwent robotic repair versus patients who 
underwent traditional repair (Suri et al., 2012). A postsurgical QOL survey was mailed to 202 
patients who underwent CMVR or RMVR between January 2008 and November 2009. The 
QOL survey consisted of the Duke Activity Status Index, Short Form-12 Item Health Survey, and 
Linear Analogue Self-Assessment Frequency for chest pain and fatigue; these components 
measure pain and activity levels post-surgery. In both surgical approaches, patients scored 
excellent results in the QOL survey. However, patients who underwent robotic repair scored 
slightly higher in the QOL survey versus patients who underwent the traditional repair (Suri et 
al., 2012).  
 The results of this study show that patients who receive RMVR may experience higher 
levels of life satisfaction post-surgery compared with patients who receive the traditional 
approach. Specifically, patients who underwent RMVR may experience lower pain associated 
with recovery and even a faster recovery time.   
Conclusion 
The aim of this literature review is to address how the implementation of RMVR affects 
surgical outcomes for patients with degenerative mitral valve disease. The surgical outcomes 
discussed from primary literature include mitral valve durability, hospital stay time, CB and XC 
time, stroke risk, mortality risk, and quality of life. From analyzing the surgical outcomes of 
RMVR, the literature suggests that RMVR has acceptable surgical outcomes for patients, and 
sometimes superior outcomes when compared with the conventional approach.  
Echocardiographic data from studies strongly support that RMVR has acceptable short 
term and long-term mitral valve durability, indicating the repair can be done successfully through 
the robotic approach. In addition to quality repairs, the mortality risk through RMVR is 
acceptable and similar to mortality risks associated with the traditional approach. These results 
suggest that patients who undergo RMVR are not at a higher risk of death.  
However, assessing the CB and XC times show that the RMVR is associated with much 
longer procedural times. Although longer CB and XC times increase the risk for stroke, the risk 
for stroke is acceptable for RMVR and similar to the stroke risk associated with the traditional 
approach. Essentially, the longer procedural time with RMVR is not enough to increase the risk 
for stroke, suggesting patients who undergo RMVR are not at a higher risk for surgical 
complications.  
The literature also shows that patients who undergo RMVR experience superior 
recovery times. This is possible since the RMVR uses a thoracotomy to reach the heart while 
the traditional approach uses a more invasive sternotomy. In addition to superior recovery 
times, patients who undergo RMVR seem to experience a higher quality of life when compared 
with the traditional approach based off survey questionnaires. These components strongly 
suggest that patient may be able to return to daily level of activities much sooner if they undergo 
RMVR.  
Overall, the implementation of robotic assisted mitral valve repair maintains and 
improves surgical outcomes in patients with degenerative mitral valve disease. From analyzing 
the literature, none of the studies examined the mitral valve durability of patients greater than 5 
years post-operation. To better understand whether RMVR has acceptable surgical outcomes 
for patients in the long term (>5 years), a study should be done to compare echocardiographic 
outcomes of patients who underwent RMVR and CMVR. The results of this study will indicate 
which procedure provides superior repairs, and an indication of how effective RMVR is for 
patients in the long term. The procedure with superior repairs will provide patients with longer 
lasting mitral valves, which is essential for basic heart function and day to day activities. The 
long-term durability of a repair can help influence which approach is implemented more at 
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